Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALBRECHT HEYDER

NPI
1073524146
CMS profile
138830
Location
ELIZABETH CITY, NC

General Payments · PY2018–2024

$4,029.44

  • Reported across 151 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$228.55

10 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $228.55 10

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Inspire Medical Systems, Inc. $72.99 2
GlaxoSmithKline, LLC. $66.51 4
Mylan Specialty L.P. $50.79 2
Acerta Pharma LLC $38.26 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,114.55 34
PY2019 $296.75 15
PY2020 $476.45 28
PY2021 $204.29 17
PY2022 $390.19 25
PY2023 $318.66 22
PY2024 $228.55 10

Payment records · PY2024 (10)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $18.78 01/24/2024 Food and Beverage Undisputed 01/23/2026 1110537401 CMS
AstraZeneca Pharmaceuticals LP $19.48 03/20/2024 Food and Beverage Undisputed 01/23/2026 1110554656 CMS
GlaxoSmithKline, LLC. $14.93 01/17/2024 Food and Beverage Undisputed 01/23/2026 1116242560 CMS
GlaxoSmithKline, LLC. $16.62 03/12/2024 Food and Beverage Undisputed 01/23/2026 1115757651 CMS
GlaxoSmithKline, LLC. $20.04 07/23/2024 Food and Beverage Undisputed 01/23/2026 1116679053 CMS
GlaxoSmithKline, LLC. $14.92 09/18/2024 Food and Beverage Undisputed 01/23/2026 1116298002 CMS
Inspire Medical Systems, Inc. $43.54 04/10/2024 Food and Beverage Undisputed 01/23/2026 1148060007 CMS
Inspire Medical Systems, Inc. $29.45 05/29/2024 Food and Beverage Undisputed 01/23/2026 1148060009 CMS
Mylan Specialty L.P. $27.14 03/27/2024 Food and Beverage Undisputed 01/23/2026 1147335800 CMS
Mylan Specialty L.P. $23.65 08/29/2024 Food and Beverage Undisputed 01/23/2026 1147299150 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.